This is not an Certified Security Engineer Braindump. All of these questions are honestly sources, as they come from my AWS ...

Wars between drug gangs in the Nordic country are the origin of numerous shootings, bombings, and murders that have occurred ...

Positive results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care FLOT (fluorouracil, leucovorin, ...

Eli Lilly and Company today announced results from the primary overall survival (OS) analysis of the Phase 3 monarchE trial showing that two years of adjuvant Verzenio plus endocrine therapy (ET) ...

The five-year invasive disease-free survival (iDFS) rates were 85.5% in the Kisqali plus ET arm versus 81.0% in the ET alone arm, representing a clinically meaningful 4.5% improvement 1. These ...

Positive results from the POTOMAC Phase III trial showed adding one year of treatment with AstraZeneca’s IMFINZI® (durvalumab) to BCG induction and maintenance therapy demonstrated a statistically ...

By reducing staff and access to treatment, the suspension of USAID and other funding threatens the country’s progress in HIV ...

(BOT), a multifunctional, Fc-enhanced CTLA-4 antibody and balstilimab (BAL), a PD-1 inhibitor, combination demonstrating durable survival ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's human epidermal growth factor receptor 2 (HER2)-directed antibody-drug conjugate (ADC) trastuzumab ...

OnePlus has officially announced that its next major software update, OxygenOS 16, based on Android 16, will start rolling ...

OnePlus has officially unveiled OxygenOS 16, its latest software update based on Android 16, featuring a refreshed design, ...